Search - tctmd.com

Displaying 21 - 40 of 66

Sort: Relevancy | Date

Presentation TCT 2019

In-Stent Restenosis: How Does Atherectomy Figure in These Cases?

Presenter: Nicolas Shammas

September 25, 2019

Presentation TCT Abstracts Posters 2019

Excimer Laser Coronary Angioplasty for Stent Under-Expansion: Single Center Experience and Outcomes

Presenter: John Nan

September 25, 2019

Presentation TCT 2019

TCT 65: Long-Term Outcomes of In-Stent Restenosis Percutaneous Coronary Intervention Among Medicare Beneficiaries

Presenter: Hector Tamez

September 25, 2019

Presentation TCT 2019

TCT 48: Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial) : Very late device thrombosis while on extended DAPT

Presenter: Robert-Jan Van Geuns

September 25, 2019

Presentation TCT 2019

TCT 56: Impact of Neoatherosclerosis on clinical Outcomes after Repeat Revascularization of In-Stent Restenosis of 2nd Generation Drug-Eluting Stents

Presenter: Zhaoyang Chen

September 25, 2019

Presentation TCT 2019

TCT 63: Jetstream Atherectomy for the Treatment of In-stent Restenosis of the Femoropopliteal Artery: Preliminary Results of the JET-ISR Study

Presenter: Nicolas Shammas

September 25, 2019

Presentation TCT 2019

TCT 53: Impact of Intravascular Ultrasound Utilization on Outcomes Following Percutaneous Coronary Intervention for In-stent Restenosis

Presenter: Evan Shlofmitz

September 25, 2019

Presentation TCT 2019

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Presenter: Binita Shah

September 25, 2019

News Industry News

Concept Medical Inc. Granted 'Breakthrough Device Designation' From the FDA for Its MagicTouch AVF Sirolimus Coated Balloon

August 29, 2019

News Daily News

PET May Be Able to Pinpoint PAD Patients at Risk of Restenosis

Caitlin E. Cox

August 15, 2019

News Daily News

CT Perfusion Imaging for In-Stent Restenosis Shows Promise

Yael L. Maxwell

August 15, 2019

News Industry News

2nd ‘Breakthrough Device Designation’ granted to Concept Medical Inc. by FDA for MagicTouch PTA Sirolimus Coated Balloon

August 13, 2019

News Industry News

Boston Scientific Responds to the FDA’s Guidance on Use of Peripheral Paclitaxel Devices for Treatment of PAD

August 07, 2019

News Opinion Off Script

Off Script: Through ‘Paclitaxelgate,’ Some Upsides to Uncertainty

Sahil Parikh, MD

July 29, 2019

News Daily News

DCB Match DES Through 1 Year in Femoropopliteal Lesions, DRASTICO Affirms

Caitlin E. Cox

July 11, 2019

Presentation TVT 2019

Restenosis of a Transcatheter Aortic Valve

Presenter: Janarthanan Sathananthan

June 13, 2019

News Daily News

FDA Review Affirms Mortality Signal With Paclitaxel-Based Devices for PAD Ahead of Panel Meeting

L.A. McKeown

June 10, 2019

News Conference News SCAI 2019

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

Yael L. Maxwell

May 30, 2019

News Industry News

EFFPAC RCT 24-month has revealed in EuroPCR 2019 that Luminor DCB demonstrate a non-increase of risk of death at 24-month follow-up

May 23, 2019

News Conference News EuroPCR 2019

EFFPAC: Novel Paclitaxel DCB for PAD Demonstrates Efficacy With No Mortality Signal

L.A. McKeown

May 23, 2019

Advertisement

In-Stent Restenosis: How Does Atherectomy Figure in These Cases?

Excimer Laser Coronary Angioplasty for Stent Under-Expansion: Single Center Experience and Outcomes

TCT 65: Long-Term Outcomes of In-Stent Restenosis Percutaneous Coronary Intervention Among Medicare Beneficiaries

TCT 48: Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial) : Very late device thrombosis while on extended DAPT

TCT 56: Impact of Neoatherosclerosis on clinical Outcomes after Repeat Revascularization of In-Stent Restenosis of 2nd Generation Drug-Eluting Stents

TCT 63: Jetstream Atherectomy for the Treatment of In-stent Restenosis of the Femoropopliteal Artery: Preliminary Results of the JET-ISR Study

TCT 53: Impact of Intravascular Ultrasound Utilization on Outcomes Following Percutaneous Coronary Intervention for In-stent Restenosis

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Concept Medical Inc. Granted 'Breakthrough Device Designation' From the FDA for Its MagicTouch AVF Sirolimus Coated Balloon

PET May Be Able to Pinpoint PAD Patients at Risk of Restenosis

CT Perfusion Imaging for In-Stent Restenosis Shows Promise

2nd ‘Breakthrough Device Designation’ granted to Concept Medical Inc. by FDA for MagicTouch PTA Sirolimus Coated Balloon

Boston Scientific Responds to the FDA’s Guidance on Use of Peripheral Paclitaxel Devices for Treatment of PAD

Off Script: Through ‘Paclitaxelgate,’ Some Upsides to Uncertainty

DCB Match DES Through 1 Year in Femoropopliteal Lesions, DRASTICO Affirms

Restenosis of a Transcatheter Aortic Valve

FDA Review Affirms Mortality Signal With Paclitaxel-Based Devices for PAD Ahead of Panel Meeting

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

EFFPAC RCT 24-month has revealed in EuroPCR 2019 that Luminor DCB demonstrate a non-increase of risk of death at 24-month follow-up

EFFPAC: Novel Paclitaxel DCB for PAD Demonstrates Efficacy With No Mortality Signal

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content